Pathology & Laboratory Medicine

You are here

News

Dr. Pengbo Zhou receives 5-year R01 from the NCI

Please join us in congratulating Dr. Pengbo Zhou on receiving a $1.3M 5-year R01 from the National Cancer Institute (NCI).

Pengbo Zhou, PhD Professor of Pathology and Laboratory Medicine

 

The focus of the study is to establish the mechanistic role of the CUL4B ubiquitin ligase in the pathogenesis of colon cancer.  Dr. Zhou will also identify small molecule inhibitors of CUL4B and test their efficacy in treating colon cancer.

Congratulations, Dr. Zhou!

Dr. Nancy Du Receives $1.3M NIH/NCI Grant

Please join us in congratulating Dr. Nancy Du for receiving a 5-year $1.3M NIH/NCI grant entitled “Beyond Apoptosis, Bcl-xL in Tumor Metastasis.”

Nancy Du, PhD Assistant Professor of Pathology and Laboratory Medicine

The focus of these studies will be to elucidate the cellular pathways that are regulated by Bcl-xL to promote cell migration and how the aberrant regulation of these pathways contributes to the formation of metastatic lesions in cancer.   

Congratulations, Dr. Du!

Dr. Mark Rubin Receives 3-Year R01 Award

Please join us in congratulating Dr. Mark Rubin on receiving a 3-year R01 award for $500k.

Along with his collaborator at Yale, Dr. Mark Gerstein, Dr. Rubin will develop approaches to identify non-coding mutations that are important for prostate cancer. 

Mark A Rubin, MD Director, Institute for Precision Medicine

Weill Cornell Medicine Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464 Fax: (212) 746-8192